LAVAL, QC, July 7 /PRNewswire-FirstCall/ - Labopharm Inc. (TSX: DDS, NASDAQ:DDSS) today announced that James R. Howard-Tripp, President and Chief Executive Officer of the Company, will present at the Leerink Swann & Company/MEDACorp Pain Roundtable Conference at Le Parker Meridien, New York on July 10, 2006 at 1:15 p.m. (ET).
